Related Experiment Video
Updated: Jul 12, 2026

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry
Published on: August 13, 2021
Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6)
Anikó Bozsik1, Szabolcs Kökény, Edith Olah
1National Institute of Oncology, Department of Molecular Genetics, Budapest, H-1122, Hungary.
Background:
Inositol hexakisphosphate (IP6), a naturally occurring polyphosphorylated carbohydrate, has been reported to have significant in vivo and in vitro anticancer activity against numerous tumors. However, the molecular mechanism of the anticancer effect of IP6 has not been fully elucidated.
Materials And Methods:
Using K-562 human leukemia cells we analysed the induction of the erythroid differentiation program, as well as modulation of the gene expression profile of K-562 leukemia cells treated with IP6.
Results:
A single treatment with IP6 (0.75 or 5.0 mM) resulted in a time- and dose-dependent growth inhibition of K-562 cells and also activation of the erythroid differentiation program. K-562 cells expressed a concomitant differentiation after 12 hours of exposure. Possible molecular mechanisms and key signaling pathways, as well as gene expression behind this anticancer effect were examined using oligonucleotide microarrays and quantitative real-time PCR. Treatment with IP6 (750 microM, 5 mM) had a marked impact, resulting in early (60 min) and late (12 h) modulation of expression of about 1800 and 1200 transcripts (at p<0.05). Through microarray analysis, the anticancer effect of IP6 in K-562 was found to be associated with the modulation of multiple genes involved in immunity, Wnt and IGF pathways, PI3 kinase signaling and apoptosis. Using selected subsets of genes, the microarray hits could be validated by Q-PCR. A 2-fold upregulation of the apoptosis pathway, measured using the BAX/BCL-2 ratio was observed for 12 hours. IP6 (5 mM) induced up to 6-fold increases in differentiation measured by hemoglobin synthesis, yielding up to 70% of benzidine-positive cells at 120 hours.
Conclusion:
The results of this study show that IP6 is a strong inducer of differentiation (cytostatic effect) and a moderately strong inducer of apoptosis (cytotoxic effect). Evidence has been provided to show that the growth inhibitory effects of IP6 are mediated through the modulation of key signaling pathways.
Insights
Inositol hexakisphosphate (IP6) inhibits leukemia cell growth by inducing differentiation and apoptosis. This study reveals IP6 modulates key signaling pathways, offering insights into its anticancer effects.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Inositol hexakisphosphate (IP6) exhibits anticancer properties against various tumors.
- The precise molecular mechanisms underlying IP6's anticancer activity remain largely unelucidated.
Purpose of the Study:
- To investigate the molecular mechanisms of IP6's anticancer effects in K-562 human leukemia cells.
- To analyze the induction of erythroid differentiation and gene expression modulation by IP6.
Main Methods:
- K-562 human leukemia cells were treated with IP6.
- Oligonucleotide microarrays and quantitative real-time PCR (Q-PCR) were employed to analyze gene expression profiles.
- Erythroid differentiation was assessed via hemoglobin synthesis and benzidine staining.
Main Results:
- IP6 demonstrated dose- and time-dependent inhibition of K-562 cell growth.
- IP6 treatment activated the erythroid differentiation program and modulated approximately 1800-1200 transcripts.
- Gene expression analysis revealed IP6's association with immunity, Wnt, IGF, PI3 kinase pathways, and apoptosis, with a 2-fold upregulation of the apoptosis pathway (BAX/BCL-2 ratio).
- IP6 significantly increased hemoglobin synthesis, with up to 70% benzidine-positive cells at 120 hours.
Conclusions:
- IP6 acts as a potent inducer of differentiation (cytostatic) and a moderate inducer of apoptosis (cytotoxic).
- The growth-inhibitory effects of IP6 are mediated through the modulation of critical cellular signaling pathways.
More Related Videos
09:01Extraction and Quantification of Soluble, Radiolabeled Inositol Polyphosphates from Different Plant Species using SAX-HPLC
Published on: June 26, 2020
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
Drugs that Stabilize Microtubules
Abnormal Proliferation